Northwestern Medicine Antimicrobial Stewardship

Review the latest information on visitor policies, safety procedures, vaccines and more in the COVID-19 Resource Center.

Antimicrobial Resources

Meet Our Team

Research

Residency and Fellowship

Educational Materials

Welcome to Northwestern Medicine Antimicrobial Stewardship

NM COVID-19 Resources

Please note: these resources are being made available based on limited evidence and will continue to be updated every two weeks, or sooner if appropriate. If using these resources, please understand this information will continue to change as the COVID-19 situation evolves in Chicago and across the United States.
Last updated: 3/5/2021

Northwestern Medicine Inpatient Treatment Options

Additional COVID-19 Resources

Medication Therapy

Bamlanivimab
https://www.covid19.lilly.com/bamlanivimab/hcp
Bamlanivimab and Etesevimab
https://www.covid19.lilly.com/bam-ete
Casirivimab and imdevimab (Regeneron)
https://www.regeneron.com/casirivimab-imdevimab

Vaccines

Janssen (Johnson and Johnson)
https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/index.html
Moderna
https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html
Pfizer
https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/index.html

Center of Excellence: Northwestern Memorial Hospital

Our Mission

To ensure that our patients receive the safest and most effective antimicrobial therapy for their infection while preserving and protecting the effectiveness of these endangered resources for future patients.

Pharmacy Residency and Fellowship Program Highlight

The Society of Infectious Diseases Pharmacists highlighted the joint Midwestern University & Northwestern Memorial Hospital pharmacy residency and fellowship programs in the January 2020 newsletter.

To learn more and access the newsletter, follow this link.

PGY-2 ID Pharmacy Residency Program Director: Sheila Wang
PGY-2/3 ID Pharmacy Fellowship Program Director: Marc Scheetz

Information about the programs can also be found on our Residency and Fellowship Page.

Choosing Wisely: Antibiotics

Dr. Jeffrey A Linder

Clinician Antimicrobial Stewardship
Training Resources

CDC Global Antimicrobial Resistance Challenge

"Northwestern Medicine, an integrated academic health system in the Chicago area with 4,000 physicians and 30,000 employees caring for over 1.1 million patients, is committed to improving antibiotic use to ensure that these important medications remain effective treatment options. The Antimicrobial Stewardship Quality Committee commits to using local and CDC data to reduce unnecessary antibiotic use across their system. They also commit to increased use of penicillin allergy testing to remove misdiagnoses and decrease the use of broader-spectrum antibiotics. Utilizing both of these interventions will be aimed at reducing overly broad spectrum antibiotic use and emphasize their strong commitment to better patient care and combating antibiotic resistance."

See "Northwestern Medicine" on the CDC AMR Challenge Website

New
C. difficile Diagnostic Algorithm

Northwestern Medicine is launching a new Clostridioides difficile diagnostic algorithm across the healthcare system. Below are clinical decision support tools to guide providers through this transition.

FAQs: NM Diagnosis and Treatment of C. difficile Infection

C. difficile Infection Testing Algorithm: PCR/Reflex Toxin EIA

NMH Go-Live: 5/4/2021
All other sites, except Northwest Region: 7/24/2021
*subject to change, will update periodically